Transforming Discovery & Translational Research
Into Disease Modifying Therapeutics
Now in it’s 7th year, the World CNS Summit is considered to be the premier industry-specific conference targeting neurodegenerative diseases.
The reason for it’s success so far is the unique strategic focus, scientific quality, and progressive nature of the presentations shared. The World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting, to examine mechanisms of disease and emerging paradigms and strategies for targeting.
We combine this with an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees.
The meeting remains committed to targeting neurodegenerative diseases and challenging traditional thinking around disease aetiology.
Our mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing a forum that helps overcome the translational barriers in developing efficacious therapeutics.
So, why attend?
- A high-quality scientific program covering new research and areas for opportunities for targeted therapeutics
- A multidisciplinary mix of participants representing consortia, leading scientists and pharmaceutical business leaders
- Niche central focus on the tackling the critical translational challenges hindering the successful development of the next generation of therapeutics
- A concerted attempt to provide an ambiance at the conference that encourages interaction, exchange of ideas and networking opportunities among all participants